what you should know about fda project optimus for your oncology drug approval
Published 1 year ago • 2.1K plays • Length 42:27Download video MP4
Download video MP3
Similar videos
-
59:00
what is fda project optimus and how will it impact oncology drug development?
-
54:26
what oncology drug developers should expect from the fda’s project optimus
-
31:44
echalk talk: how oncology drug developers can prepare for fda’s project optimus
-
1:05:36
project optimus – fda’s new dose optimization & selection paradigm in oncology drug development
-
12:07
the fda’s "project optimus" and oncology drugs
-
57:36
project optimus & pediatric drug development
-
55:19
how to define & measure clinical endpoints to optimize your oncology drug dosing
-
29:20
fda oncology drug development overview – past to present
-
37:28
the future of robotics as a service with saman farid of formic
-
4:18
antibody conjugates: what you need to know | cst tech tips
-
16:44
how doctors can help ai to revolutionize medicine
-
57:06
small molecules, biologics, and vaccines: three uniquely divergent roads to fda cmc approval
-
50:09
an overview of fda's project facilitate oncology expanded access program
-
3:48
fda oncology center of excellence’s project facilitate
-
35:08
fda modernization act - what does it mean for pharmaceutical scientists?
-
1:24
fda oncology center of excellence’s project facilitate
-
1:00:16
fda modernization act 2.0 – what does it mean for drug developers?
-
55:32
using clinical pharmacology & pharmacometrics to accelerate car-t development
-
57:16
antibody-drug conjugates in the clinic:
-
55:36
lmsdr webinar: fda oncology product development
-
43:49
how can model informed drug development impact your program?
-
2:26
what is the fda's case for quality initiative?